Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.20.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balances at beginning at Dec. 31, 2018 $ 110,183 $ 108,600,405 $ (107,199,586) $ 1,511,002
Balances at beginning (in shares) at Dec. 31, 2018 11,018,364      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Cumulative adjustment for adoption of new accounting standard     (244) (244)
Share-based compensation $ 285 152,301   152,586
Share-based compensation (in shares) 28,462      
Warrant exercises $ 204 (204)    
Warrant exercises (in shares) 20,381      
Net loss for the period     (1,220,725) (1,220,725)
Balances at ending at Mar. 31, 2019 $ 110,672 108,752,502 (108,420,555) 442,619
Balance at ending (in shares) at Mar. 31, 2019 11,067,207      
Balances at beginning at Dec. 31, 2018 $ 110,183 108,600,405 (107,199,586) 1,511,002
Balances at beginning (in shares) at Dec. 31, 2018 11,018,364      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss for the period       (2,771,120)
Balances at ending at Jun. 30, 2019 $ 136,863 116,741,229 (109,970,950) 6,907,142
Balance at ending (in shares) at Jun. 30, 2019 13,686,320      
Balances at beginning at Mar. 31, 2019 $ 110,672 108,752,502 (108,420,555) 442,619
Balances at beginning (in shares) at Mar. 31, 2019 11,067,207      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Cumulative adjustment for adoption of new accounting standard     (244) (244)
Share-based compensation $ 32 203,962   203,994
Share-based compensation (in shares) 3,251      
Warrant exercises $ 1,894 381,182   383,076
Warrant exercises (in shares) 189,407      
Private placement net of offering costs $ 24,265 7,403,583   7,427,848
Private placement (in shares) 2,426,455      
Net loss for the period     (1,550,395) (1,550,395)
Balances at ending at Jun. 30, 2019 $ 136,863 116,741,229 (109,970,950) 6,907,142
Balance at ending (in shares) at Jun. 30, 2019 13,686,320      
Balances at beginning at Dec. 31, 2019 $ 152,353 117,173,984 (112,739,620) 4,586,717
Balances at beginning (in shares) at Dec. 31, 2019 15,235,308      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation $ 97 227,871   227,968
Share-based compensation (in shares) 9,696      
Warrant exercises $ 2,621 (2,621)    
Warrant exercises (in shares) 262,145      
Net loss for the period     (2,054,825) (2,054,825)
Balances at ending at Mar. 31, 2020 $ 155,071 117,399,234 (114,794,445)  
Balance at ending (in shares) at Mar. 31, 2020 15,507,149      
Balances at beginning at Dec. 31, 2019 $ 152,353 117,173,984 (112,739,620) 4,586,717
Balances at beginning (in shares) at Dec. 31, 2019 15,235,308      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss for the period       (3,715,873)
Balances at ending at Jun. 30, 2020 $ 155,127 117,640,195 (116,455,493) 1,339,829
Balance at ending (in shares) at Jun. 30, 2020 15,512,687      
Balances at beginning at Mar. 31, 2020 $ 155,071 117,399,234 (114,794,445)  
Balances at beginning (in shares) at Mar. 31, 2020 15,507,149      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation $ 56 240,961   241,017
Share-based compensation (in shares) 5,538      
Net loss for the period     (1,661,048) (1,661,048)
Balances at ending at Jun. 30, 2020 $ 155,127 $ 117,640,195 $ (116,455,493) $ 1,339,829
Balance at ending (in shares) at Jun. 30, 2020 15,512,687